Kwang Dong Pharmaceutical Co., Ltd.
KSC: 009290.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sung-Won Choi
- Employees
- 1,040
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩294.4B
- Website
- https://www.ekdp.com
Loading 009290…
Loading profile data…Frequently asked questions about 009290
What does Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) do?
Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arterioscle...
Where does 009290.KS trade?
Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) trades on the Korea Exchange.
What sector is 009290.KS in?
Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kwang Dong Pharmaceutical Co., Ltd.?
Sung-Won Choi is the chief executive officer of Kwang Dong Pharmaceutical Co., Ltd. (009290.KS).
Where is Kwang Dong Pharmaceutical Co., Ltd. headquartered?
Kwang Dong Pharmaceutical Co., Ltd. is headquartered in South Korea.
Does 009290.KS pay a dividend?
Yes — Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) paid a trailing twelve-month dividend of KRW 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 009290.KS go public?
Kwang Dong Pharmaceutical Co., Ltd. (009290.KS) completed its initial public offering in 2000.